Malaria Vaccines

Showing 1 - 7 of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Malaria Trial in Worldwide (Blood sampling, Assessment of body temperature)

Recruiting
  • Malaria
  • Malaria Vaccines
  • Blood sampling
  • Assessment of body temperature
  • Nouna, Burkina Faso
  • +11 more
Sep 8, 2022

Diseases Specified as Adverse Events of Special Interest, of

Active, not recruiting
  • Malaria
  • Malaria Vaccines
  • Blood collection
  • Ouagadougou, Burkina Faso
  • +4 more
Oct 18, 2021

Malaria, Malaria Vaccines Trial in Kintampo, Kumasi (Vitamin A, Candidate Plasmodium falciparum malaria vaccine, MR-Vac)

Completed
  • Malaria
  • Malaria Vaccines
  • Vitamin A
  • +3 more
  • Kintampo, Ghana
  • +1 more
Sep 7, 2021

Malaria, Malaria Vaccines Trial in Dar-es-Salaam (RTS,S/AS02D, Engerix-B®, TETRActHib™)

Completed
  • Malaria
  • Malaria Vaccines
  • RTS,S/AS02D
  • +2 more
  • Dar-es-Salaam, Tanzania
    GSK Investigational Site
Oct 8, 2020

Malaria, Malaria Vaccines Trial in Worldwide (Blood sampling, Assessment of body temperature)

Completed
  • Malaria
  • Malaria Vaccines
  • Blood sampling
  • Assessment of body temperature
  • Ouagadougou 01, Burkina Faso
  • +7 more
Aug 5, 2020

Malaria, Malaria Vaccines Trial in Ouagadougou 01, Kumasi (GlaxoSmithKline (GSK) Biologicals' candidate Plasmodium falciparum

Completed
  • Malaria
  • Malaria Vaccines
  • GlaxoSmithKline (GSK) Biologicals' candidate Plasmodium falciparum malaria vaccine 257049
  • +7 more
  • Ouagadougou 01, Burkina Faso
  • +1 more
Jul 4, 2019

Malaria, Malaria Vaccines, Plasmodium Falciparum Malaria Trial (Malaria Transmission-Blocking Pfs25-Pfs25 Conjugate Vaccine)

Withdrawn
  • Malaria
  • +2 more
  • Malaria Transmission-Blocking Pfs25-Pfs25 Conjugate Vaccine
  • (no location specified)
Jul 3, 2018